BDBM485866 US10947196, Compound 03-2

SMILES CC(C)(C)NC[C@H](O)c1cc(ccn1)C(F)(F)F

InChI Key InChIKey=PXSPIPWMEYLBOD-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 485866   

TargetBeta-2 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485866(US10947196, Compound 03-2)
Affinity DataEC50:  550nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485866(US10947196, Compound 03-2)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent